Strata Critical Medical (SRTA) Capital Expenditures (2021 - 2026)

Strata Critical Medical (SRTA) has 6 years of Capital Expenditures data on file, last reported at $5.2 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $5.2 million, up 1427.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (up 132.72% YoY), and the FY2025 annual result was $128000.0, down 65.87% from the prior year.
• Capital Expenditures climbed to $5.2 million in Q1 2026 per SRTA's latest filing, from -$7.6 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $7.6 million in Q3 2024 and troughed at -$25.9 million in Q4 2024.
• A 5-year average of -$641307.7 and a median of $816000.0 in 2024 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2024 and 2026: Capital Expenditures sank 1142.73% in 2024, then soared 1427.73% in 2026.
• A 5-year view of Capital Expenditures shows it stood at $626000.0 in 2022, then plunged by 433.07% to -$2.1 million in 2023, then slumped by 1142.73% to -$25.9 million in 2024, then soared by 70.6% to -$7.6 million in 2025, then surged by 167.97% to $5.2 million in 2026.
• Business Quant data shows SRTA's Capital Expenditures at $5.2 million in Q1 2026, -$7.6 million in Q4 2025, and $2.8 million in Q3 2025.